Engineering immune-evasive allogeneic cellular immunotherapies
Allogeneic cellular immunotherapies hold a great promise for cancer treatment owing to
their potential cost-effectiveness, scalability and on-demand availability. However, immune …
their potential cost-effectiveness, scalability and on-demand availability. However, immune …
CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells
T Bexte, N Albinger, A Al Ajami, P Wendel… - Nature …, 2024 - nature.com
Chimeric antigen receptor (CAR)-modified natural killer (NK) cells show antileukemic activity
against acute myeloid leukemia (AML) in vivo. However, NK cell-mediated tumor killing is …
against acute myeloid leukemia (AML) in vivo. However, NK cell-mediated tumor killing is …
Deletion of the TMEM30A gene enables leukemic cell evasion of NK cell cytotoxicity
L Kristenson, C Badami, A Ljungberg… - Proceedings of the …, 2024 - National Acad Sciences
Natural killer (NK) cell immunotherapy has gained attention as a promising strategy for
treatment of various malignancies. In this study, we used a genome-wide CRISPR screen to …
treatment of various malignancies. In this study, we used a genome-wide CRISPR screen to …
Functional genomics identifies N-acetyllactosamine extension of complex N-glycans as a mechanism to evade lysis by natural killer cells
Natural killer (NK) cells are primary defenders against cancer precursors, but cancer cells
can persist by evading immune surveillance. To investigate the genetic mechanisms …
can persist by evading immune surveillance. To investigate the genetic mechanisms …
Hypersialylation and multiple myeloma
There is growing recognition of the importance of sialylation as a critical post translational
modification in cancer. In this article we review the role of increased cell surface sialylation …
modification in cancer. In this article we review the role of increased cell surface sialylation …
[HTML][HTML] Proteolytic cleavage of Golgi glycosyltransferases by SPPL3 and other proteases and its implications for cellular glycosylation
M Voss - Biochimica et Biophysica Acta (BBA)-General Subjects, 2024 - Elsevier
Glycosylation of proteins and lipids is of fundamental importance in multicellular eukaryotes.
The vast diversity of glycan structures observed is generated in the Golgi apparatus by the …
The vast diversity of glycan structures observed is generated in the Golgi apparatus by the …
[HTML][HTML] Strategies to disrupt NKG2A: HLA-E interactions for improved anti-cancer immunity
JG Fisher, LV Graham, MD Blunt - Oncotarget, 2024 - ncbi.nlm.nih.gov
The inhibitory receptor NKG2A, which forms a heterodimer with CD94, is expressed by~
50% of peripheral blood NK cells and is further upregulated following NK cell expansion ex …
50% of peripheral blood NK cells and is further upregulated following NK cell expansion ex …
The G Protein–Coupled Receptor GPR56 Is an Inhibitory Checkpoint for NK Cell Migration
D Palacios, RK Majhi, EK Szabo, D Clement… - The Journal of …, 2024 - journals.aai.org
G protein–coupled receptors (GPCRs) represent the largest family of surface receptors and
are responsible for key physiological functions, including cell growth, neurotransmission …
are responsible for key physiological functions, including cell growth, neurotransmission …
[HTML][HTML] IFNγ mediates the resistance of tumor cells to distinct NK cell subsets
T Hofman, SW Ng, I Garcés-Lázaro… - … for Immunotherapy of …, 2024 - ncbi.nlm.nih.gov
Background Immune checkpoint blockade targeting the adaptive immune system has
revolutionized the treatment of cancer. Despite impressive clinical benefits observed, patient …
revolutionized the treatment of cancer. Despite impressive clinical benefits observed, patient …
Highlight of 2023: Unlocking the therapeutic potential of natural killer cells-advances in adaptive functions, cellular engineering and immunotherapy.
PY Lam… - Immunology and Cell …, 2024 - europepmc.org
Natural killer (NK) cells possess potent cytotoxicity against infected and cancerous cells and
hold promise in the development of new immunotherapies. This article for the Highlights of …
hold promise in the development of new immunotherapies. This article for the Highlights of …